Kangmei Pharma | 600518 - Operating Profit


Kangmei Pharma reported CNY-35.26M in Operating Profit for its fiscal quarter ending in June of 2026.





Operating Profit Change Date
Akebia Therapeutics USD -5.45M 9.4M Dec/2025
Alaunos Therapeutics USD -1.01M 175K Mar/2026
Avita Medical AUD -10.41M 742K Dec/2025
Cspc Pharmaceutical CNY 206.26M 1.02B Dec/2025
Dianthus Therapeutics USD -46.53M 23.01M Mar/2026
Genomma Lab Internacional MXN 877.2M 2.78M Jun/2026
Hypermarcas BRL 505.89M 141.31M Mar/2026
Ionis Pharmaceuticals USD -102.29M 15.71M Jun/2026
IQVIA Holdings USD 2.6B 2.03B Jun/2026
Jiangsu Hengrui CNY 1.68B 876.54M Jun/2026
Kangmei Pharma CNY -35.26M 24.32M Jun/2026
Moderna USD -815M 573M Jun/2026
Organon & Co USD 323M 57M Jun/2026
Revvity USD 126.14M 43.36M Jun/2026
Sh Fosun Pharma CNY 561.95M 255.94M Jun/2026
Tectonic Therapeutic USD -27.3M 5.78M Mar/2026
Viatris USD 73.7M 93.9M Jun/2026
Wuxi Apptec CNY 7.83B 2.72B Jun/2026
Xeris Pharmaceuticals USD 7.92M 8.86M Mar/2026
Zz Pientze Pharmaceu CNY 362.83M 474.98M Jun/2026